par Osowicki, Joshua;Azzopardi, Kristy;Baker, Ciara A;Waddington, Claire Shelley;Pandey, Manisha;Schuster, Tibor;Grobler, Anneke;Cheng, Allen C;Pollard, Andrew John;McCarthy, James J.S.;Good, Michael F;Walker, Mark J;Dale, James B;Batzloff, Michael;Carapetis, Jonathan Rhys;Smeesters, Pierre
;Steer, Andrew C
Référence Vaccine, 37, 26, page (3485-3494)
Publication Publié, 2019-07-01
;Steer, Andrew CRéférence Vaccine, 37, 26, page (3485-3494)
Publication Publié, 2019-07-01
Article révisé par les pairs
| Titre: |
|
| Auteur: | Osowicki, Joshua; Azzopardi, Kristy; Baker, Ciara A; Waddington, Claire Shelley; Pandey, Manisha; Schuster, Tibor; Grobler, Anneke; Cheng, Allen C; Pollard, Andrew John; McCarthy, James J.S.; Good, Michael F; Walker, Mark J; Dale, James B; Batzloff, Michael; Carapetis, Jonathan Rhys; Smeesters, Pierre; Steer, Andrew C |
| Informations sur la publication: | Vaccine, 37, 26, page (3485-3494) |
| Statut de publication: | Publié, 2019-07-01 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Controlled human infection |
| Group A Streptococcus | |
| Human challenge | |
| Human infection studies | |
| Streptococcus pyogenes | |
| Vaccine development | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0264-410X |
| info:doi/10.1016/j.vaccine.2019.03.059 | |
| info:pii/S0264-410X(19)30405-0 | |
| info:scp/85065551948 | |
| info:pmid/31101422 |



